These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 2711157

  • 1. [A single infusion of Pamidronate (APD) in Paget's disease of bone].
    Thiébaud D, Jaeger P, Jacquet AF, Burckhardt P.
    Schweiz Med Wochenschr; 1989 Jan 21; 119(3):71-4. PubMed ID: 2711157
    [Abstract] [Full Text] [Related]

  • 2. A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone.
    Thiébaud D, Jaeger P, Gobelet C, Jacquet AF, Burckhardt P.
    Am J Med; 1988 Aug 21; 85(2):207-12. PubMed ID: 3261129
    [Abstract] [Full Text] [Related]

  • 3. Paget's disease of bone treated in five days with AHPrBP (APD) per Os.
    Thiébaud D, Jaeger P, Burckhardt P.
    J Bone Miner Res; 1987 Feb 21; 2(1):45-52. PubMed ID: 3455156
    [Abstract] [Full Text] [Related]

  • 4. [Paget's disease of bone treated per os with APD in 5 days].
    Thiébaud D, Jaeger P, Burckhardt P.
    Schweiz Med Wochenschr; 1986 Dec 13; 116(50):1787-9. PubMed ID: 3798071
    [Abstract] [Full Text] [Related]

  • 5. Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).
    Harinck HI, Papapoulos SE, Blanksma HJ, Moolenaar AJ, Vermeij P, Bijvoet OL.
    Br Med J (Clin Res Ed); 1987 Nov 21; 295(6609):1301-5. PubMed ID: 3120987
    [Abstract] [Full Text] [Related]

  • 6. Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone.
    Cantrill JA, Buckler HM, Anderson DC.
    Ann Rheum Dis; 1986 Dec 21; 45(12):1012-8. PubMed ID: 3813665
    [Abstract] [Full Text] [Related]

  • 7. Effects of intravenous pamidronate therapy on Paget's disease of bone.
    Bombassei GJ, Yocono M, Raisz LG.
    Am J Med Sci; 1994 Oct 21; 308(4):226-33. PubMed ID: 7942981
    [Abstract] [Full Text] [Related]

  • 8. [Moderate Paget's disease treated with pamidronate (APD): experience in 43 patients with a single 60 mg infusion of varying duration of 1-to-24 hours].
    Thiébaud D, Portmann L, Burckhardt P.
    Schweiz Med Wochenschr; 1992 Dec 05; 122(49):1889-94. PubMed ID: 1462150
    [Abstract] [Full Text] [Related]

  • 9. A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone.
    Chakravarty K, Merry P, Scott DG.
    J Rheumatol; 1994 Nov 05; 21(11):2118-21. PubMed ID: 7869320
    [Abstract] [Full Text] [Related]

  • 10. Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
    Gutteridge DH, Retallack RW, Ward LC, Stuckey BG, Stewart GO, Prince RL, Kent GN, Bhagat CI, Price RI, Thompson RI, Nicholson GC.
    Bone; 1996 Oct 05; 19(4):387-94. PubMed ID: 8894145
    [Abstract] [Full Text] [Related]

  • 11. Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate (APD).
    Stone MD, Hawthorne AB, Kerr D, Webster G, Hosking DJ.
    J Bone Miner Res; 1990 Dec 05; 5(12):1231-5. PubMed ID: 2075835
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of the bisphosphonate APD in the control of Paget's bone disease.
    Mautalen CA, Gonzalez D, Ghiringhelli G.
    Bone; 1985 Dec 05; 6(6):429-32. PubMed ID: 4096879
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of Paget's disease of bone with aminohydroxybutylidene bisphosphonate.
    O'Doherty DP, Bickerstaff DR, McCloskey EV, Hamdy NA, Beneton MN, Harris S, Mian M, Kanis JA.
    J Bone Miner Res; 1990 May 05; 5(5):483-91. PubMed ID: 2195845
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The treatment of Paget's disease of bone with second-generation bisphosphonates via intravenous infusion].
    Arboleya L, Sánchez J, Iglesias G, Arranz JL.
    Rev Clin Esp; 1993 Dec 05; 193(9):467-71. PubMed ID: 8108576
    [Abstract] [Full Text] [Related]

  • 19. Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone.
    Arden-Cordone M, Siris ES, Lyles KW, Knieriem A, Newton RA, Schaffer V, Zelenakas K.
    Calcif Tissue Int; 1997 May 05; 60(5):415-8. PubMed ID: 9115157
    [Abstract] [Full Text] [Related]

  • 20. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
    Walsh JP, Ward LC, Stewart GO, Will RK, Criddle RA, Prince RL, Stuckey BG, Dhaliwal SS, Bhagat CI, Retallack RW, Kent GN, Drury PJ, Vasikaran S, Gutteridge DH.
    Bone; 2004 Apr 05; 34(4):747-54. PubMed ID: 15050907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.